Bevacizumab for Retinopathy of Prematurity


Gilbert, CE; Zin, A; Darlow, B; (2011) Bevacizumab for Retinopathy of Prematurity. The New England journal of medicine, 364 (24). 2359-60; author reply 2361-2. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMc1103460#SA2

[img]
Preview
Text - Published Version
License: Copyright the publishers

Download (438kB) | Preview
Item Type: Article
Keywords: Angiogenesis Inhibitors, therapeutic use, Antibodies, Monoclonal, therapeutic use, Developing Countries, Humans, Infant, Newborn, Infant, Premature, Intravitreal Injections, Laser Therapy, Retinopathy of Prematurity, drug therapy, therapy, Vascular Endothelial Growth Factor A, antagonists & inhibitors
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
Research Centre: The International Centre for Evidence in Disability
International Centre for Eye Health
Centre for Global Non-Communicable Diseases (NCDs)
PubMed ID: 21675898
Web of Science ID: 291643800018
URI: http://researchonline.lshtm.ac.uk/id/eprint/561

Statistics


Download activity - last 12 months
Downloads since deposit
291Downloads
318Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item